lower
respiratori
tract
infect
upper
respiratori
tract
infect
urti
common
etiolog
diagnos
routin
practic
object
studi
determin
compar
frequenc
distribut
variou
infecti
etiolog
diseas
one
hundr
seventi
five
adult
commun
febril
lrti
febril
urti
includ
pure
serolog
base
prospect
studi
pair
sera
obtain
patient
test
eia
immunofluoresc
method
identifi
differ
pathogen
signific
chang
antibodi
titer
pair
sera
consid
diagnost
least
one
infecti
etiolog
identifi
patient
lrti
group
infect
least
one
respiratori
virus
found
patient
one
atyp
pathogen
found
patient
legionella
spp
mycoplasma
pneumonia
bacteri
etiolog
found
patient
streptococcu
pneumonia
streptococci
group
frequenc
distribut
etiolog
urti
group
significantli
differ
lrti
group
except
pneumonia
identifi
one
patient
urti
p
one
etiolog
agent
found
patient
lrti
caus
broad
spectrum
etiolog
respiratori
virus
predomin
moder
signific
preval
atyp
pathogen
frequenc
distribut
etiolog
urti
similar
lrti
signific
proport
patient
urti
lrti
serolog
evid
infect
one
pathogen
justif
benefit
distinguish
urti
lrti
routin
clinic
work
doubt
decis
reach
treat
rti
patient
antibiot
logic
use
macrolid
tetracyclin
respiratori
tract
infect
rti
common
commun
one
major
reason
appoint
primari
care
physician
particularli
winter
season
macfarlan
et
al
broad
diagnosi
rti
includ
two
princip
subdiagnos
lower
respiratori
tract
infect
lrti
upper
respiratori
tract
infect
urti
although
often
difficult
distinguish
vast
major
rti
case
run
benign
cours
justifi
routin
practic
invest
effort
mean
identifi
precis
etiolog
primari
care
physician
call
upon
reach
manag
decis
rti
patient
base
decis
among
factor
known
frequenc
distribut
etiolog
type
infect
data
literatur
etiolog
billa
gleckman
macfarlan
et
al
monto
cavallaro
verheij
et
al
base
primarili
studi
util
advanc
diagnost
techniqu
develop
recent
aim
present
studi
use
innov
new
serolog
method
identifi
variou
infecti
etiolog
febril
rti
among
adult
commun
light
accept
divis
lrti
urti
addit
aim
studi
compar
frequenc
distribut
infecti
etiolog
two
subgroup
studi
includ
patient
went
primari
care
physician
emerg
room
cours
three
month
januari
march
met
inclus
criteria
studi
agre
particip
studi
inclus
criteria
age
year
acut
febril
ill
less
one
week
durat
patient
report
least
one
temperatur
measur
home
neighborhood
clinic
emerg
room
reach
least
po
patient
least
one
follow
four
complaint
cough
coryza
sore
throat
hoars
women
might
definit
pregnant
exclud
patient
known
posit
hiv
three
primari
care
clinic
klalit
health
servic
largest
sick
fund
israel
three
differ
neighborhood
southern
israel
citi
beersheva
particip
studi
board
certifi
specialist
famili
medicin
work
clinic
particip
studi
second
sourc
patient
enrol
emerg
room
soroka
medic
center
patient
enrol
studi
sourc
condit
met
inclus
criteria
discharg
shortli
turn
emerg
room
without
hospit
studi
approv
committe
research
human
be
helsinki
committe
soroka
medic
center
particip
gave
inform
consent
patient
identifi
meet
studi
inclus
criteria
gave
inform
consent
interview
famili
physician
emerg
room
physician
use
detail
structur
questionnair
physic
examin
focus
patient
complaint
find
associ
respiratori
tract
infect
throat
cultur
taken
patient
research
assist
also
drew
ml
venou
blood
serolog
test
shortli
afterward
blood
sampl
separ
serum
frozen
serolog
test
perform
patient
underw
chest
xray
pa
later
treatment
decis
reach
treat
physician
without
intervent
studi
team
telephon
followup
symptom
conduct
followup
team
h
interv
followup
focus
question
continu
fever
appear
new
symptom
continu
presenc
disappear
respiratori
tract
symptom
telephon
followup
continu
patient
free
complaint
gradual
return
hisher
usual
schedul
activ
three
four
week
enter
studi
patient
invit
followup
visit
meet
second
blood
sampl
drawn
patient
convalesc
phase
serolog
patient
posit
throat
cultur
suspect
pneumonia
acut
phase
ill
also
underw
repeat
throat
cultur
chest
xray
accordingli
pneumonia
diagnos
patient
suspect
lung
infiltr
disappear
clear
significantli
followup
xray
data
analysi
stage
patient
divid
lrti
group
urti
group
purpos
adopt
macfarlan
definit
lrti
macfarlan
accord
lrti
diagnos
presenc
cough
least
one
purul
sputum
dyspnea
chest
pain
discomfort
wheez
andor
new
focal
crepit
reduc
breath
sound
lung
auscult
enrol
patient
meet
diagnost
criteria
lrti
defin
urti
etiolog
workup
studi
base
almost
exclus
serolog
test
except
rule
group
streptococci
diagnos
presenc
posit
standard
throat
cultur
bacterium
taken
acut
phase
ill
condit
followup
throat
cultur
convalesc
phase
neg
serolog
test
conduct
pathogen
known
caus
upper
lower
rti
identifi
serolog
test
serolog
test
two
serum
sampl
test
run
patient
method
kit
criteria
use
reach
serolog
diagnos
follow
antibodi
level
mycoplasma
pneumonia
determin
commerci
enzym
immunoassay
eia
kit
savyon
diagnost
israel
kit
antibodi
level
specif
igm
igg
iga
antibodi
determin
separ
pneumonia
consid
etiolog
rti
signific
chang
accord
formula
manufactur
instruct
antibodi
level
found
acut
convalesc
serum
sampl
serolog
test
coxiella
burnetii
perform
use
indirect
immunofluoresc
method
antigenco
slide
biolog
institut
nesziona
israel
use
c
burnetii
strain
qnm
serv
antigen
c
burnetii
consid
etiolog
rti
presenc
fourfold
greater
chang
antic
burnetii
phase
ii
igg
andor
igm
antibodi
titer
pair
serum
sampl
antibodi
differ
serogroup
legionella
spp
detect
use
indirect
immunofluoresc
method
heatkil
legionella
serv
antigen
pool
sera
test
igm
treatment
goat
antibodi
human
igg
antibodi
legionella
spp
consid
etiolog
caus
rti
fourfold
greater
increas
igg
andor
igm
titer
pair
serum
sampl
detect
chlamydophila
chlamydia
pneumoniaespecif
serum
igg
iga
igm
level
determin
microimmunofluoresc
mif
method
use
commerci
kit
serofiachlamydia
savyon
diagnost
ashdod
israel
elementari
bodi
c
pneumonia
washington
research
foundat
usa
use
antigen
sera
test
igm
treatment
goat
antibodi
human
igg
antibodi
sera
test
three
antibodi
class
serial
twofold
dilut
endpoint
c
pneumonia
consid
etiolog
rti
presenc
fourfold
chang
one
three
antibodi
class
pair
serum
sampl
antibodi
level
seven
respiratori
virus
influenza
influenza
b
parainfluenza
respiratori
syncyti
viru
adenoviru
determin
eia
use
specif
commerci
kit
detect
igg
iga
igm
seven
virus
genzym
virotec
germani
infect
seven
virus
consid
etiolog
rti
signific
chang
virotec
unit
adjust
od
antibodi
level
found
first
second
serum
sampl
patient
immun
influenza
six
month
prior
present
ill
increas
antibodi
titer
two
sera
consid
diagnost
acut
infect
influenza
b
decreas
antibodi
titer
virus
attribut
effect
immun
igg
antibodi
level
pneumococc
protein
toxin
pneumolysin
produc
bacillu
subtili
cpolysaccharid
isol
pneumococc
mutant
strain
cpolysaccharid
capsul
cmutant
csr
clone
method
pedersen
et
al
pedersen
et
al
measur
enzym
immunoassay
eia
twofold
greater
increas
antibodi
level
pair
sera
consid
diagnost
streptococcu
pneumonia
infect
jalonen
et
al
jalonen
et
al
pneumoniaespecif
immun
complex
determin
measur
antibodi
level
pneumolysin
cpolysaccharid
precipit
redissolv
immun
complex
holloway
et
al
leinonen
et
al
cutoff
valu
posit
deriv
result
obtain
test
immun
complex
bound
antibodi
healthi
adult
mean
thu
etiolog
diagnosi
current
pneumococc
infect
caus
rti
base
presenc
signific
chang
level
pneumococc
antibodi
presenc
specif
immun
complex
serum
total
antibodi
level
nonencapsul
hemophilu
influenza
burman
et
al
moraxella
catarrhali
claesson
leinonen
leinonen
et
al
measur
eia
use
whole
bacteri
cell
antigen
threefold
increas
antibodi
level
pair
sera
consid
diagnost
current
h
influenza
catarrhali
infect
etiolog
rti
serolog
test
pneumonia
h
influenza
catarrhali
conduct
nation
public
health
institut
depart
oulu
finland
result
analyz
use
statist
softwar
epi
info
test
equival
serv
compar
proport
group
analysi
varianc
anova
done
compar
continu
variabl
among
two
group
statist
signific
set
p
two
hundr
fifti
patient
compris
studi
popul
one
hundr
fifti
patient
enrol
studi
primari
care
set
other
emerg
room
accord
classif
describ
patient
diagnos
lrti
urti
tabl
present
comparison
demograph
data
smoke
histori
chronic
comorbid
two
group
patient
without
except
came
followup
appoint
convalesc
serum
sampl
drawn
patient
mean
interv
day
rang
day
acut
phase
sampl
diseas
cours
patient
benign
recov
complet
without
signific
complic
need
hospit
tabl
show
comparison
clinic
manifest
acut
respiratori
tract
infect
two
group
comparison
done
clinic
paramet
serv
diagnost
criteria
lrti
comparison
would
meaningless
tabl
present
frequenc
distribut
variou
infecti
etiolog
identifi
two
group
comparison
least
one
infecti
etiolog
identifi
patient
lrti
group
urti
group
seen
tabl
statist
signific
differ
group
mycoplasma
pneumonia
rel
low
rate
c
pneumonia
infect
stem
diagnost
requir
fourfold
increas
antibodi
titer
acut
convalesc
phase
sera
also
use
pathogen
relat
high
antibodi
titer
without
chang
pair
sera
evid
acut
infect
c
pneumonia
would
identifi
pathogen
patient
lrti
group
patient
urti
group
patient
pneumococc
infect
diagnos
signific
chang
level
pneumococc
antibodi
detect
one
patient
diagnosi
base
presenc
specif
pneumococc
immun
complex
two
sera
patient
least
one
legionella
spp
identifi
etiolog
rti
uniqu
interest
group
light
uniqu
would
worthwhil
detail
specif
legionella
spp
identifi
clinic
manifest
infect
respons
antibiot
therapi
patient
compar
other
howev
degre
detail
would
beyond
scope
present
paper
deal
infecti
etiolog
found
studi
popul
thu
patient
describ
discuss
detail
paper
devot
specif
issu
lieberman
et
al
patient
one
etiolog
identifi
repres
studi
popul
patient
least
one
etiolog
found
distribut
etiolog
per
patient
two
group
comparison
shown
tabl
despit
absenc
statist
signific
differ
rate
paramet
two
group
clear
trend
higher
rate
one
etiolog
lrti
group
compar
urti
group
among
patient
viral
respiratori
tract
infect
addit
bacteri
agent
patient
viral
respiratori
tract
infect
togeth
atyp
bacteri
agent
four
patient
combin
infect
bacteri
atyp
bacteri
agent
three
pathogen
identifi
one
patient
agent
belong
one
group
four
patient
infect
one
agent
group
pathogen
nineteen
patient
lrti
group
diagnos
communityacquir
pneumonia
cap
patient
least
one
infecti
agent
identifi
two
patient
mix
etiolog
respiratori
viru
atyp
bacteria
one
patient
combin
viral
agent
c
pneumonia
pneumonia
one
patient
mix
infect
viral
agent
c
burnetii
posit
throat
cultur
group
streptococci
frequenc
distribut
etiolog
rti
adult
patient
commun
determin
previou
studi
lieberman
et
al
conduct
two
year
ago
pilot
studi
present
one
small
sampl
size
studi
difficulti
distinguish
clinic
ground
lrti
urti
two
subgroup
unit
titl
rti
lesson
learn
studi
studi
use
methodolog
particular
bear
serolog
criteria
diagnosi
acut
infect
broad
rang
respiratori
pathogen
test
use
accept
serolog
criteria
previou
studi
consid
high
antibodi
titer
particularli
igm
iga
case
c
pneumonia
igg
well
unchang
pair
sera
evid
acut
infect
specif
agent
diagnost
approach
increas
sensit
test
reduc
specif
could
certain
use
criteria
identifi
case
repres
actual
acut
infect
persist
high
antibodi
titer
result
previou
infect
express
chronic
infect
specif
pathogen
thu
present
studi
diagnos
acut
infect
presenc
signific
increas
antibodi
titer
level
pair
sera
one
specif
immunoglobulin
strategi
increas
confid
identifi
pathogen
inde
etiolog
caus
rti
time
reduc
sensit
test
respons
least
part
find
one
third
patient
infecti
agent
unknown
etiolog
diagnos
studi
base
almost
entir
serolog
respons
pair
sera
broad
rang
respiratori
pathogen
awar
theoret
possibl
antibodi
respons
upon
diagnos
base
could
nonspecif
despit
effort
reduc
problem
minimum
discuss
howev
prefer
serolog
test
isol
pathogen
respiratori
secret
microbi
cultur
method
may
low
sensit
pathogen
even
potenti
pathogen
isol
secret
way
prove
presenc
due
contamin
unrel
diseas
especi
case
pneumococcu
h
influenza
catarrhali
belong
normal
microbi
flora
upper
respiratori
tract
contrast
signific
chang
antibodi
titer
specif
pathogen
pair
sera
usual
indic
signific
associ
pathogen
host
high
level
probabl
causeeffect
relationship
pathogen
diseas
among
inclus
criteria
studi
mandatori
requir
fever
measur
time
patient
visit
physician
result
requir
case
febril
rti
includ
although
without
doubt
mani
case
rti
involv
fever
ground
decis
desir
exclud
patient
met
inclus
criteria
whose
complaint
result
allerg
cough
coryza
acut
infect
requir
fever
effect
prevent
opinion
inclus
patient
studi
order
compar
frequenc
distribut
differ
infecti
etiolog
lrti
urti
group
defin
lrti
comprehens
survey
definit
lrti
acut
bronchiti
use
investig
differ
studi
show
number
definit
similar
number
studi
macfarlan
among
definit
propos
chose
use
macfarlan
definit
macfarlan
despit
problem
involv
applic
seem
logic
use
definit
lrti
brought
situat
mani
patient
urti
lrti
symptom
defin
lrti
situat
taken
account
interpret
result
studi
comprehens
search
literatur
one
studi
broad
rang
etiolog
lrti
among
adult
commun
found
macfarlan
et
al
studi
pneumococcu
domin
etiolog
almost
nonexist
preval
atyp
pathogen
popul
studi
significantli
older
higher
rate
chronic
comorbid
particularli
chronic
respiratori
problem
popul
pneumococc
etiolog
diagnos
studi
presenc
bacterium
antigen
sputum
contrast
present
studi
purpos
avoid
approach
discuss
spectrum
etiolog
test
studi
includ
legionella
spp
diagnost
method
virus
atyp
pathogen
much
less
sensit
use
present
studi
methodolog
differ
studi
provid
explan
strike
differ
etiolog
distribut
found
two
studi
frequenc
distribut
lrti
found
studi
point
clear
domin
viral
etiolog
signific
rate
atyp
pathogen
etiolog
particularli
pneumonia
variou
legionella
spp
small
portion
classic
bacteri
etiolog
distribut
found
studi
closer
appear
literatur
name
acut
bronchiti
caus
frequent
virus
less
commonli
pneumonia
rare
bacteri
pathogen
name
legionella
spp
bordetella
pertussi
gleckman
believ
differ
present
studi
studi
preval
legionella
spp
due
progress
made
past
decad
serolog
diagnost
techniqu
identif
pathogen
progress
manifest
result
studi
avail
studi
conduct
ten
year
ago
find
relat
sever
specif
etiolog
requir
discuss
c
pneumonia
identifi
two
patient
lrti
group
percentag
low
absolut
rel
term
rate
infect
pathogen
report
previou
studi
grayston
et
al
reason
low
rate
c
pneumonia
infect
contrast
previou
studi
studi
diagnos
acut
infect
pathogen
presenc
signific
increas
antibodi
titer
pair
sera
contrast
earlier
studi
high
antibodi
titer
consid
diagnost
acut
infect
even
without
chang
pair
sera
today
high
igg
iga
titer
c
pneumonia
without
chang
acut
convalesc
phase
sera
copd
patient
view
evid
chronic
infect
pathogen
von
hertzen
et
al
thu
decid
would
wrong
diagnosi
patient
studi
high
antibodi
titer
suffer
acut
infect
pathogen
use
paramet
would
identifi
patient
serolog
posit
c
pneumonia
lrti
group
urti
group
addit
high
posit
rate
absolut
term
method
would
demonstr
sharp
differ
rate
infect
pathogen
lrti
urti
report
past
grayston
et
al
contrast
studi
etiolog
lrti
identifi
low
even
miniscul
rate
infect
legionella
spp
found
patient
etiolog
rate
posit
among
lrti
patient
among
urti
patient
princip
reason
differ
present
previou
studi
number
type
specif
serogroup
includ
head
legionella
spp
vast
major
previou
studi
l
pneumophila
identifi
case
serotyp
serogroup
legionella
caus
sever
ill
larg
percentag
infect
patient
involv
lung
parenchyma
respons
appar
report
cap
necessit
hospit
intens
care
unit
hirani
macfarlan
woodhead
et
al
contrast
present
studi
test
serogroup
legionella
spp
addit
serotyp
sinc
signific
chang
antibodi
titer
found
patient
legionella
spp
least
one
serogroup
reason
assum
signific
associ
serogroup
rti
three
known
respiratori
tract
bacteria
name
pneumonia
h
influenza
catarrhali
test
use
innov
serolog
techniqu
routin
use
preval
rate
bacteria
studi
low
find
contrast
strongli
result
previou
studi
found
posit
serolog
rate
pneumonia
hospit
cap
patient
lieberman
et
al
strike
differ
preval
rate
pneumonia
two
popul
found
even
though
test
done
laboratori
use
method
believ
differ
provid
evid
high
level
reliabl
test
indic
although
pneumonia
common
etiolog
among
hospit
cap
patient
preval
low
among
lrti
urti
patient
commun
inevit
limit
studi
type
result
may
specif
relat
factor
season
year
age
group
patient
composit
geograph
area
although
year
studi
conduct
atyp
frequenc
viral
infect
epidem
pneumonia
infect
three
studi
month
includ
januari
februari
regular
season
peak
influenza
b
infect
basi
previou
epidemiolog
studi
monto
cavallaro
reason
assum
distribut
etiolog
pediatr
age
group
even
region
differ
result
present
studi
third
patient
evid
defin
infecti
etiolog
despit
intens
investig
pair
sera
believ
two
primari
explan
find
first
criteria
specif
etiolog
diagnosi
includ
unchang
high
antibodi
titer
sera
requir
explain
increas
diagnost
specif
appar
reduc
sensit
lead
classif
unknown
etiolog
patient
second
may
viral
etiolog
rhinoviru
coronaviru
known
caus
acut
bronchiti
gleckman
technic
difficult
diagnos
possibl
patient
studi
infect
virus
although
gener
rule
infect
caus
afebril
ill
gleckman
patient
studi
febril
one
quarter
patient
studi
etiolog
found
one
pathogen
identifi
associ
one
infecti
agent
develop
respiratori
tract
infect
well
known
verheij
et
al
attribut
past
bacteri
infect
secondari
viral
infect
two
studi
use
advanc
serolog
techniqu
assess
etiolog
cap
hospit
patient
report
high
rate
patient
evid
one
etiolog
kauppinen
et
al
lieberman
et
al
studi
like
present
one
found
possibl
combin
pathogen
associ
bacteria
virus
sinc
rti
cap
involv
infect
system
overlap
featur
like
pathophysiolog
explan
given
phenomenon
multipl
etiolog
cap
lieberman
et
al
valid
rti
well
despit
absenc
statist
signific
small
number
patient
clear
trend
increas
rate
multipl
etiolog
lrti
group
compar
urti
group
differ
togeth
rate
patient
one
etiolog
cap
lead
conclus
phenomenon
increas
preval
infect
involv
lower
region
respiratori
tract
ie
lowest
urti
higher
lrti
highest
cap
phenomenon
view
opposit
perspect
ie
pathogen
involv
infect
infecti
process
involv
lower
region
respiratori
system
divis
rti
urti
lrti
problemat
term
primari
physician
daili
clinic
routin
overlap
mani
express
infect
two
part
respiratori
tract
overlap
particularli
well
demonstr
tabl
present
comparison
clinic
manifest
two
group
show
clinic
sign
characterist
one
type
infect
also
appear
rel
high
rate
divis
rti
also
necessari
pathophysiolog
ground
sinc
upper
lower
respiratori
tract
continu
ciliari
structur
mucosa
ident
theoret
standpoint
import
diagnos
treat
patient
cap
antibiot
rti
patient
without
cap
pharyng
tonsil
caus
group
streptococci
beyond
latter
two
diagnos
therapeut
signific
differenti
urti
lrti
sinc
neither
case
clear
cut
justif
antibiot
therapi
anoth
aspect
might
provid
justif
divis
rti
etiolog
distribut
import
find
studi
respect
signific
differ
frequenc
distribut
infecti
etiolog
urti
lrti
except
pneumonia
relev
question
pose
whether
higher
rate
pneumonia
respiratori
tract
infect
meet
criteria
lrti
justifi
differenti
diagnosi
urti
lrti
believ
question
remain
unansw
moment
therapeut
signific
result
complex
predomin
viral
etiolog
type
infect
support
antibiot
therapi
signific
moder
rate
atyp
agent
would
appear
support
antibiot
treatment
although
least
patient
diseas
selflimit
antibiot
therapi
affect
outcom
classic
bacteri
etiolog
identifi
low
rate
patient
rti
subgroup
reason
assum
antibiot
therapi
would
favor
effect
outcom
patient
result
studi
contradict
convent
approach
antibiot
therapi
indic
rti
gleckman
least
use
controversi
billa
event
result
studi
indic
rti
patient
treat
physician
decid
prescrib
antibiot
choic
macrolid
tetracyclin
conclud
lrti
caus
broad
rang
etiolog
agent
viral
predomin
moder
signific
rate
atyp
bacteri
etiolog
frequenc
distribut
etiolog
urti
similar
lrti
signific
percent
rti
patient
evid
one
etiolog
agent
need
distinguish
urti
lrti
routin
primari
care
work
doubt
decis
reach
treat
rti
patient
antibiot
logic
choic
macrolid
tetracyclin
